Brief: Galectin Therapeutics Reports Quarterly Loss Per Share Of $0.15
16/08/2021 14:14
Aug 16 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
QUARTER
ENDED JUNE 30, 2021, AND PROVIDES BUSINESS UPDATE
* QUARTERLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nGNX6DSy8w
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study